MedPath

Spiden AG

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

Non-invasive Measurement of Glucose with Advanced Spectroscopy Techniques and Machine Learning Models

Not Applicable
Completed
Conditions
Healthy
Interventions
Device: Lab demo 1.0
First Posted Date
2024-05-09
Last Posted Date
2025-03-10
Lead Sponsor
Liom Health AG
Target Recruit Count
43
Registration Number
NCT06406075
Locations
🇨🇭

Liom Health AG, Pfäffikon, Schwyz, Switzerland

Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)

Not Applicable
Recruiting
Conditions
Type2diabetes
Type 1 Diabetes
Interventions
Device: Clinical Demo 2.0
First Posted Date
2024-02-22
Last Posted Date
2024-09-30
Lead Sponsor
Liom Health AG
Target Recruit Count
80
Registration Number
NCT06272136
Locations
🇩🇪

Profil for Stoffwechselforschung GmbH, Neuss, Nordrhein-Westfallen, Germany

A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults with Type-1 Diabetes Mellitus

Not Applicable
Completed
Conditions
Type 1 Diabetes Mellitus
Type 1 Diabetes Mellitus with Hypoglycemia
Type 1 Diabetes Mellitus with Hyperglycemia
Interventions
Device: Lab Demo 1.0
First Posted Date
2023-10-24
Last Posted Date
2024-09-30
Lead Sponsor
Liom Health AG
Target Recruit Count
21
Registration Number
NCT06097689
Locations
🇨🇭

Markus Laimer, Berne, Switzerland

© Copyright 2025. All Rights Reserved by MedPath